Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR

Shuo Shen, Andrew Y. Fu, Maidar Jamba, Jonathan Li, Mike J. Powell, Aiguo Zhang, Chuanyi M. Lu, View ORCID ProfileMichael Y. Sha
doi: https://doi.org/10.1101/2021.04.01.21254484
Shuo Shen
1DiaCarta Inc., 2600 Hilltop Dr, Richmond, CA 94806.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Y. Fu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maidar Jamba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mjamba@diacarta.com msha@diacarta.com
Jonathan Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike J. Powell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aiguo Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chuanyi M. Lu
2University of California and VA, Healthcare System, San Francisco, CA 94121.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Y. Sha
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Y. Sha
  • For correspondence: mjamba@diacarta.com msha@diacarta.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

We applied XNA-based Molecular Clamping Technology to develop a multiplex qPCR assay for rapid and accurate detection of SARS-CoV-2 mutations. A total of 278 previously tested SARS-COV-2 positive samples originating primarily from San Francisco Bay Area were tested, including 139 Samples collected in middle January and 139 samples collected at the end of February 2021, respectively. The SARS-CoV-2 Spike-gene D614G mutation was detected from 58 samples (41.7%) collected in January 2021 and, 78 samples (56.1%) collected in February. Notably, while there were no N501Y mutation detected in samples from January, seven of the February samples were tested positive for the N501Y and D614G mutations. The results suggest a relatively recent and speedy spreading of the UK variant (B.1.1.7) in Northern California. This new Molecular Clamping technology-based multiplex RT-qPCR assay is highly sensitive and specific and can help speed up large scale testing for SARS-CoV-2 variants.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

N/A

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Deidentified leftover patient nasopharyngeal swab (NPS) and saliva samples were used in the study. All patient specimens were collected in January and February 2021 and previously tested at UCSF affiliated San Francisco VA Medical Center clinical laboratory and DiaCarta CLIA certified clinical laboratory for clinical diagnostic or screening purpose. Other than qualitative RT-PCR results (positive or negative), only PCR cycle threshold (Ct) values were included in study analysis and no patient clinical chart reviews were performed. This study was approved by the institutional review board (IRB) at UCSF (UCSF IRB #11-05207) as a no-subject contact study with waiver of consent and as exempt under category 4.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

all data referred to in the manuscript are available to public.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR
Shuo Shen, Andrew Y. Fu, Maidar Jamba, Jonathan Li, Mike J. Powell, Aiguo Zhang, Chuanyi M. Lu, Michael Y. Sha
medRxiv 2021.04.01.21254484; doi: https://doi.org/10.1101/2021.04.01.21254484
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR
Shuo Shen, Andrew Y. Fu, Maidar Jamba, Jonathan Li, Mike J. Powell, Aiguo Zhang, Chuanyi M. Lu, Michael Y. Sha
medRxiv 2021.04.01.21254484; doi: https://doi.org/10.1101/2021.04.01.21254484

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (496)
  • Anesthesia (106)
  • Cardiovascular Medicine (1110)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (275)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (505)
  • Epidemiology (9796)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2327)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1567)
  • Health Policy (737)
  • Health Systems and Quality Improvement (608)
  • Hematology (238)
  • HIV/AIDS (508)
  • Infectious Diseases (except HIV/AIDS) (11669)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2154)
  • Nursing (134)
  • Nutrition (340)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (519)
  • Oncology (1185)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (221)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (314)
  • Pediatrics (699)
  • Pharmacology and Therapeutics (303)
  • Primary Care Research (268)
  • Psychiatry and Clinical Psychology (2195)
  • Public and Global Health (4685)
  • Radiology and Imaging (786)
  • Rehabilitation Medicine and Physical Therapy (458)
  • Respiratory Medicine (625)
  • Rheumatology (276)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (212)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)